Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 711-720 of 1759 for cancer

Edit search filters
  1. Maintain Respiratory Muscle Function And Reduce Pneumonia Risk In Cancer Patients

    Rochester, MN

  2. A Study Of Oral LOXO-305 In Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Or Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs To Treat Patients With Mantle Cell Lymphoma

    Jacksonville, FL, Rochester, MN

  4. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight

    Rochester, MN

  5. A Trial To Evaluate Multiple Regimens In Newly Diagnosed And Recurrent Glioblastoma

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate AuTophagy Activation For Cardiomyopathy Due To Anthracycline TReatment

    Rochester, MN

  7. Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients with Early Stage Non-Small Lung Cancer (NSCLC)

    Rochester, MN

  8. Actinium Therapy For Late-stage Aggressive Sarcomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate Durvalumab Alone Or In Combination With Novel Agents In Subjects With NSCLC

    Scottsdale/Phoenix, AZ

  10. NKX101, Intravenous Allogeneic CAR NK Cells, In Adults With AML Or MDS

    Jacksonville, FL

.

Mayo Clinic Footer